Obat-obatan: Utama
Perusahaan Perusahaan Argentina yang beroperasi di satu industri: obat-obatan: utama
Daftar di bawah berisi Perusahaan Argentina yang beroperasi di industri yang sama, obat-obatan: utama. Daftar ini membantu melacak kinerja mereka, laporan laba rugi, dan banyak lagi. Diurutkan berdasarkan metrik yang diperlukan, ini dapat menunjukkan saham-saham industri yang paling mahal seperti ASTRAZENECA CEDEAR EACH REP 0.5 ADR USD0.25 atau saham-saham dengan dinamika harga terbaik seperti ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD), sehingga membantu anda dalam merancang strategi dalam fokus apa pun.
Simbol | Kap Pasar | Harga | Perubahan % | Volume | Volume Relatif | P/E | EPS terdilusi TTM | Pertumbuhan EPS terdilusi TTM YoY | Imbal hasil dividen % TTM | Sektor | Penilaian Analis |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 617.253 T ARS | 14189.500 ARS | −0.42% | 651 | 0.30 | — | — | — | — | Teknologi Kesehatan | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 617.253 T ARS | 14.000 USD | +3.70% | 65 | 0.74 | — | — | — | — | Teknologi Kesehatan | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 305.659 T ARS | 10346.500 ARS | +1.02% | 18.002 K | 0.69 | 42.60 | 242.90 ARS | +459.57% | 0.88% | Teknologi Kesehatan | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 305.659 T ARS | 1168.000 ARS | −2.42% | 11 | 0.00 | — | — | — | — | Teknologi Kesehatan | — |
| DJN3BJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 305.659 T ARS | 1147.500 ARS | +0.48% | 1 M | 2.65 | — | — | — | — | Teknologi Kesehatan | — |
| JNJ.BJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 305.659 T ARS | 10500.000 ARS | −20.99% | 2.511 K | 0.07 | 43.23 | 242.90 ARS | +459.57% | 0.88% | Teknologi Kesehatan | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 305.659 T ARS | 10.400 USD | +2.97% | 328 | 0.37 | 36.66 | 242.90 ARS | +48.88% | 0.88% | Teknologi Kesehatan | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 276.034 T ARS | 26649.000 ARS | +0.29% | 276 | 0.46 | — | — | — | — | Teknologi Kesehatan | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 276.034 T ARS | 26.000 USD | 0.00% | 20 | 4.08 | — | — | — | — | Teknologi Kesehatan | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 253.747 T ARS | 17591.500 ARS | +0.86% | 515 | 0.23 | 21.91 | 802.79 ARS | −6.12% | 1.00% | Teknologi Kesehatan | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 253.747 T ARS | 17.750 USD | +0.28% | 33 | 0.28 | 17.87 | 802.79 ARS | −77.92% | 1.00% | Teknologi Kesehatan | — |
 AZNASTRAZENECA CEDEAR EACH REP 0.5 ADR USD0.25DR | 183.152 T ARS | 36396.500 ARS | −0.33% | 61 | 0.11 | 175.00 | 207.98 ARS | +257.80% | 1.17% | Teknologi Kesehatan | — |
| AZNDASTRAZENECA CEDEAR EA RE 0.5 ADR (USD) DR | 183.152 T ARS | 36.750 USD | −0.27% | 5 | 0.70 | 142.85 | 207.98 ARS | −15.86% | 1.17% | Teknologi Kesehatan | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 159.63 T ARS | 24670.000 ARS | −1.71% | 5 | 0.07 | — | — | — | — | Teknologi Kesehatan | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 159.63 T ARS | 23.100 USD | −3.95% | 6 | 1.03 | — | — | — | — | Teknologi Kesehatan | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 124.78 T ARS | 6734.500 ARS | −0.36% | 10.919 K | 0.46 | — | — | — | — | Teknologi Kesehatan | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 124.78 T ARS | 6.770 USD | +2.89% | 613 | 0.70 | — | — | — | — | Teknologi Kesehatan | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 122.552 T ARS | 9336.500 ARS | −0.46% | 777 | 0.41 | — | — | — | — | Teknologi Kesehatan | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 122.552 T ARS | 9.400 USD | −3.59% | 4 | 0.08 | — | — | — | — | Teknologi Kesehatan | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 85.198 T ARS | 17182.500 ARS | +1.03% | 202 | 0.58 | — | — | — | — | Teknologi Kesehatan | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 85.198 T ARS | 17.500 USD | +2.04% | 6 | — | — | — | — | — | Teknologi Kesehatan | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 70.641 T ARS | 10437.000 ARS | −1.23% | 56 | 0.22 | 53.72 | 194.30 ARS | −31.41% | 1.42% | Teknologi Kesehatan | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 70.641 T ARS | 10.200 USD | −8.52% | 100 | 5.21 | 42.44 | 194.30 ARS | −83.87% | 1.42% | Teknologi Kesehatan | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 24.103 T ARS | 15650.000 ARS | −0.63% | 238 | 0.58 | — | — | — | — | Teknologi Kesehatan | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 24.103 T ARS | 20.000 USD | +2.04% | 18 | 2.69 | — | — | — | — | Teknologi Kesehatan | — |
 RICHLABORATORIOS RICHMOND SACIF | 70.496 B ARS | 873.000 ARS | −3.00% | 20.723 K | 2.43 | — | −130.78 ARS | — | 0.00% | Teknologi Kesehatan | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4.344 B ARS | 102.000 ARS | −0.97% | 1.159 K | 0.18 | — | — | — | 0.00% | Teknologi Kesehatan | — |